Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Cash & Equivalents (2016 - 2025)

Zepp Health has reported Cash & Equivalents over the past 11 years, most recently at $57.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 37.36% year-over-year to $57.0 million; the TTM value through Dec 2025 reached $57.0 million, down 37.36%, while the annual FY2025 figure was $57.0 million, 37.36% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $57.0 million at Zepp Health, down from $61.7 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $131809.1 billion in Q4 2023 and troughed at $76429.0 in Q1 2025.
  • A 5-year average of $6658.3 billion and a median of $58.6 billion in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 105731351.96% in 2023 and later plummeted 100.0% in 2025.
  • Year by year, Cash & Equivalents stood at $229.7 million in 2021, then crashed by 45.72% to $124.7 million in 2022, then soared by 105731351.96% to $131809.1 billion in 2023, then tumbled by 100.0% to $91.1 million in 2024, then tumbled by 37.36% to $57.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for ZEPP at $57.0 million in Q4 2025, $61.7 billion in Q3 2025, and $55.4 billion in Q2 2025.